Delayed neurotoxicity and other consequences of organophosphate esters.
D000818:Animals; D002265:Carboxylic Ester Hydrolases / Q000037:antagonists & inhibitors; D002800:Cholinesterase Inhibitors; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D006077:Government Agencies; D006801:Humans; D009422:Nervous System Diseases / Q000139:chemically induced*; D009943:Organophosphorus Compounds / Q000009:adverse effects* / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014317:Tritolyl Phosphates / Q000009:adverse effects; D014481:United States; D014944:World Health Organization
D002800:Cholinesterase Inhibitors; D009943:Organophosphorus Compounds; D014317:Tritolyl Phosphates; D002265:Carboxylic Ester Hydrolases; C021859:neurotoxic esterase; C025541:tri-o-cresyl phosphate